Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Aemetis
AMTX
$134M
| $3.09M | ﹤0.01% |
422,129
+146,892
| +53% | +$558K |
|
3052
NIO
NIO
$10.9B
| $3.09M | ﹤0.01% |
+319,296
| New | +$2.7M |
|
3053
CALL
Public Storage
PSA
$58.5B
| $3.09M | ﹤0.01% |
10,600
+3,600
| +51% | +$1.05M |
|
|
HPP
3054
Hudson Pacific Properties
HPP
$713M
| $3.09M | ﹤0.01% |
104,676
+53,766
| +106% | +$1.92M |
|
3055
PUT
Establishment Labs
ESTA
$2.11B
| $3.09M | ﹤0.01% |
+45,000
| New | +$3.11M |
|
3056
Universal Electronics
UEIC
$58.2M
| $3.09M | ﹤0.01% |
320,843
-207,621
| -39% | -$1.92M |
|
3057
PUT
Charter Communications
CHTR
$18.3B
| $3.09M | ﹤0.01% |
8,400
+7,400
| +740% | +$2.53M |
|
3058
PUT
ON Semiconductor
ON
$28.3B
| $3.08M | ﹤0.01% |
32,600
-2,500
| -7% | -$207K |
|
3059
Westlake Corp
WLK
$9.68B
| $3.08M | ﹤0.01% |
25,781
+22,253
| +631% | +$2.55M |
|
3060
Caribou Biosciences
CRBU
$174M
| $3.07M | ﹤0.01% |
722,569
+397,554
| +122% | +$1.79M |
|
3061
La-Z-Boy
LZB
$1.3B
| $3.07M | ﹤0.01% |
107,086
+64,816
| +153% | +$1.81M |
|
3062
ADC Therapeutics
ADCT
$146M
| $3.06M | ﹤0.01% |
1,424,149
-369,043
| -21% | -$830K |
|
3063
Moog Inc Class A
MOG.A
$11.9B
| $3.06M | ﹤0.01% |
28,233
+16,259
| +136% | +$1.61M |
|
3064
Impinj
PI
$5.2B
| $3.04M | ﹤0.01% |
33,931
-253,029
| -88% | -$27M |
|
3065
PRA Group
PRAA
$721M
| $3.04M | ﹤0.01% |
132,967
-140,056
| -51% | -$3.88M |
|
3066
CEVA Inc
CEVA
$764M
| $3.04M | ﹤0.01% |
118,826
-54,389
| -31% | -$1.37M |
|
|
LKFT
3067
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.89B
| $3.03M | ﹤0.01% |
74,572
-275,123
| -79% | -$11.2M |
|
3068
Sinclair Inc
SBGI
$1.04B
| $3.02M | ﹤0.01% |
218,758
+142,785
| +188% | +$2.36M |
|
3069
Central Garden & Pet Co
CENT
$2.74B
| $3.02M | ﹤0.01% |
97,270
+27,486
| +39% | +$836K |
|
3070
Donnelley Financial Solutions
DFIN
$1.19B
| $3M | ﹤0.01% |
65,946
+56,734
| +616% | +$2.5M |
|
3071
Johnson Outdoors
JOUT
$481M
| $3M | ﹤0.01% |
48,852
-46,953
| -49% | -$2.81M |
|
3072
Equifax
EFX
$22.8B
| $2.99M | ﹤0.01% |
12,722
-23,827
| -65% | -$5.01M |
|
3073
Fate Therapeutics
FATE
$291M
| $2.98M | ﹤0.01% |
625,061
-1,107,926
| -64% | -$6.11M |
|
3074
Red Robin
RRGB
$176M
| $2.97M | ﹤0.01% |
215,093
-63,675
| -23% | -$854K |
|
|
SNCY
3075
DELISTED
Sun Country Airlines
SNCY
| $2.97M | ﹤0.01% |
132,041
-684,444
| -84% | -$13.1M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.